title: Clinical evaluation of genetically engineered hypoallergenic rBet v 1 derivatives.
authors.affiliation: Hôpitaux Universitaires and INSERM U-425, Strasbourg, France.
authors.forename: G
authors.initials: G
authors.lastname: Pauli
authors.forename: A
authors.initials: A
authors.lastname: Purohit
authors.forename: J P
authors.initials: JP
authors.lastname: Oster
authors.forename: F
authors.initials: F
authors.lastname: de Blay
authors.forename: S
authors.initials: S
authors.lastname: Vrtala
authors.forename: V
authors.initials: V
authors.lastname: Niederberger
authors.forename: D
authors.initials: D
authors.lastname: Kraft
authors.forename: R
authors.initials: R
authors.lastname: Valenta
mesh_terms: D000485:Allergens / Q000235:genetics / Q000276:immunology* / Q000627:therapeutic use; D052179:Antigens, Plant; D003888:Desensitization, Immunologic; D005818:Genetic Engineering; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy* / Q000276:immunology; D010940:Plant Proteins / Q000235:genetics / Q000276:immunology* / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use
chemical_list: D000485:Allergens; D052179:Antigens, Plant; D010940:Plant Proteins; D011994:Recombinant Proteins; C061312:Bet v 1 allergen, Betula